“On TV & Video” is a column exploring opportunities and challenges in advanced TV and video. Today’s column is by Marcella Milliet Sciorra, CMO of DeepIntent. Linear TV has long dominated the marketing mix for pharmaceutical brands and their agencies. In 2021, these groups spent an estimated $ 3.9 billion on national broadcast and cable ads,… Continue reading »
The post Linear Is Still The King Of Pharma, But For How Long? appeared first on AdExchanger.
More Stories
DoorDash and Live Nation ANZ announce three year partnership
Nielsen survey show magazine audiences on the rise
Google Dodged a Breakup, but Experts Say Alternatives Are Misdirected